Resultado da Busca
Bert Vogelstein (born 1949) is director of the Ludwig Center, Clayton Professor of Oncology and Pathology and a Howard Hughes Medical Institute investigator at The Johns Hopkins Medical School and Sidney Kimmel Comprehensive Cancer Center.
Bert Vogelstein (Baltimore, 2 de junho de 1949) é um médico pesquisador do câncer estadunidense. Prêmios. Prêmio Internacional da Fundação Gairdner 1992 [1] Prêmio Dickson de Medicina 1994; Prêmio Ernst Schering 1994; Prêmio Louisa Gross Horwitz 1998; Prêmio Paul Ehrlich e Ludwig Darmstaedter 1998; Prêmio William Allan 1998
Professor of Oncology. Background. Bert Vogelstein, M.D., was the first scientist to elucidate the molecular basis of a common human cancer. In particular, he and his colleagues have demonstrated that colorectal tumors result from the gradual accumulation of genetic alterations in specific oncogenes and tumor suppressor genes.
5468. 1998. Participation of p53 protein in the cellular response to DNA damage. MB Kastan, O Onyekwere, D Sidransky, B Vogelstein, RW Craig. Cancer research 51 (23_Part_1), 6304-6311. , 1991. 5327. 1991. Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC.
2 de mai. de 2024 · Bert Vogelstein (born June 2, 1949, Baltimore, Md., U.S.) is an American oncologist known for his groundbreaking work on the genetics of cancer. Vogelstein was raised in Baltimore and attended a private middle school from which he was often truant, preferring to teach himself by reading at the public library.
- The Editors of Encyclopaedia Britannica
Dr. Vogelstein is a cancer researcher and co-director of the Ludwig Center at Johns Hopkins University. He studies the molecular genetics of human cancer and develops new prevention and treatment strategies based on cancer driver genes.
17 de dez. de 2021 · Learn about the life and achievements of Bert Vogelstein, M.D., the co-director of the Ludwig Center at Johns Hopkins Kimmel Cancer Center and a Howard Hughes Medical Institute investigator. He is best known for his landmark work in deciphering and explaining the molecular genetic basis of cancer.
